Asset sale Announced
Thermo Fisher Scientific acquisition of Solventum purification and filtration (P&F) business
US$4bn consideration
Announced Sep 2025 (approx.)
Advisers
Solventum purification and filtration (P&F) business
Target
- Legal adviser
Thermo Fisher Scientific
Acquirer
Not disclosed
- Target
- Solventum purification and filtration (P&F) business
- Acquirer
- Thermo Fisher Scientific
- Seller
- Solventum Corp
- Sector
- Medical devices and technology
Similar deals
- Beijing Guoci Kebo Technology Co. acquisition of SDI Feb 2026 · A$166m · Medical devices and technology
- Alcidion Group acquisition of Kyra flow products May 2026 · A$3m · Medical devices and technology
- Blackbird stake in Heidi Oct 2026 · Medical devices and technology
- Genetic Signatures and Microba Life Sciences merger Sep 2026 · Medical devices and technology
- Smartways Logistics acquisition of SAVI Surgical Feb 2026 · Medical devices and technology